All resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog
Regression-to-the-Mean: Insights for Drug Developers from the Sports World
Regression-to-the-mean offers critical insights for drug development, like sports statistics, emphasizing the importance of understanding data variability across multiple levels of inference.
News and Events
Episode 14, “Drug Developers’ Lessons from Sports: Regression-to-the-Mean"
In this engaging episode of "In the Interim...", host Dr. Scott Berry is joined by Dr. Nick Berry to explore the intriguing parallels between sports and drug development, focusing on the concept of "regression-to-the-mean."
Podcast Episode
14: Drug Developers' Lessons from Sports: Regression-to-the-Mean
In this engaging episode of "In the Interim...", host Dr. Scott Berry is joined by Dr. Nick Berry to explore the intriguing parallels between sports and drug development, focusing on the concept of "regression-to-the-mean."
Blog
Navigating the Complex Role of DSMBs in Adaptive Clinical Trials
Understanding DSMBs is pivotal in ensuring trial integrity, safety, and success.
News and Events
Episode 13, “DSMBs in Adaptive Trials with Roger Lewis"
In this episode of "In the Interim…", host Dr. Scott Berry is true to the name of the podcast, as he discusses the unblinded world of adaptive clinical trials alongside Dr. Roger Lewis, a renowned expert in both statistical science and clinical medicine.
Podcast Episode
13: DSMBs in Adaptive Trials with Roger Lewis
In this episode of "In the Interim…", host Dr. Scott Berry is true to the name of the podcast, as he discusses the unblinded world of adaptive clinical trials alongside Dr. Roger Lewis, a renowned expert in both statistical science and clinical medicine.
No results found.
There are no results with this criteria. Try changing your search.
